Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
384.1 USD | -3.37% | +2.11% | +24.69% |
Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.69% | 12.29B | |
+0.84% | 43.84B | |
+5.63% | 41.68B | |
+45.55% | 41.25B | |
-10.92% | 27.04B | |
+7.81% | 25.53B | |
-25.62% | 18.18B | |
-3.69% | 12.29B | |
+6.94% | 11.15B | |
-19.57% | 9.98B |
- Stock Market
- Equities
- MEDP Stock
- News Medpace Holdings, Inc.
- Medpace : Significant Insider Sales Reported in Shares of Medpace Holdings (MEDP) Extending the Trend of Last Quarter